Boston Scientific Corporation (0HOY.L)

Healthcare | Medical Equipment Services
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 5,065,000,000 5,061,000,000 4,663,000,000 4,561,000,000
Cost of Revenue 1,523,000,000 1,637,000,000 1,713,000,000 1,890,000,000
Gross Profit 3,542,000,000 3,424,000,000 2,950,000,000 2,671,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,741,000,000 1,716,000,000 1,597,000,000 1,612,000,000
Operating Expenses 2,492,000,000 2,605,000,000 2,054,000,000 2,082,000,000
Operating Income 1,050,000,000 819,000,000 896,000,000 589,000,000
Interest Expense 87,000,000 90,000,000 87,000,000 139,000,000
Income Before Tax 939,000,000 941,000,000 805,000,000 585,000,000
Income Tax Expense 183,000,000 146,000,000 133,000,000 23,000,000
Net Income 755,000,000 793,000,000 674,000,000 566,000,000
Per Share
EPS 0.51 0.54 0.46 0.38
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 16,747,000,000 14,240,000,000 12,682,000,000
Cost of Revenue 6,480,000,000 4,345,000,000 4,968,000,000
Gross Profit 10,267,000,000 9,895,000,000 7,714,000,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 5,984,000,000 5,190,000,000 4,520,000,000
Operating Expenses 7,632,000,000 7,552,000,000 5,890,000,000
Operating Income 2,635,000,000 2,343,000,000 1,824,000,000
Interest Expense 387,000,000 265,000,000 464,000,000
Income Before Tax 2,282,000,000 1,985,000,000 1,141,000,000
Income Tax Expense 436,000,000 393,000,000 443,000,000
Net Income 1,854,000,000 1,593,000,000 698,000,000
Per Share
EPS 1.26 1.08 0.49
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 414,000,000 865,000,000 1,077,000,000
Short Term Investments 0 0 0
Net Receivables 2,558,000,000 2,228,000,000 1,970,000,000
Inventory 2,810,000,000 2,484,000,000 1,867,000,000
Total Current Assets 6,920,000,000 6,514,000,000 5,760,000,000
Property Plant Equipment 3,744,000,000 3,298,000,000 2,832,000,000
Goodwill and Intangibles 23,773,000,000 20,390,000,000 18,889,000,000
Total Assets 39,395,000,000 35,136,000,000 32,469,000,000
Liabilities
Account Payables 960,000,000 942,000,000 862,000,000
Short Term Debt 1,778,000,000 531,000,000 20,000,000
Total Current Liabilities 6,399,000,000 4,933,000,000 3,803,000,000
Long Term Debt 9,369,000,000 8,961,000,000 8,910,000,000
Total Liabilities 17,392,000,000 15,606,000,000 14,896,000,000
Shareholders Equity
Retained Earnings 2,673,000,000 819,000,000 -750,000,000
Total Shareholders Equity 21,770,000,000 19,282,000,000 17,573,000,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 414,000,000 865,000,000 1,077,000,000
Short Term Investments 0 0 0
Net Receivables 2,558,000,000 2,228,000,000 1,970,000,000
Inventory 2,810,000,000 2,484,000,000 1,867,000,000
Total Current Assets 6,920,000,000 6,514,000,000 5,760,000,000
Property Plant Equipment 3,744,000,000 3,298,000,000 2,832,000,000
Goodwill and Intangibles 23,773,000,000 20,390,000,000 18,889,000,000
Total Assets 39,395,000,000 35,136,000,000 32,469,000,000
Liabilities
Account Payables 960,000,000 942,000,000 862,000,000
Short Term Debt 1,778,000,000 531,000,000 20,000,000
Total Current Liabilities 6,399,000,000 4,933,000,000 3,803,000,000
Long Term Debt 9,369,000,000 8,961,000,000 8,910,000,000
Total Liabilities 17,392,000,000 15,606,000,000 14,896,000,000
Shareholders Equity
Retained Earnings 2,673,000,000 819,000,000 -750,000,000
Total Shareholders Equity 21,770,000,000 19,282,000,000 17,573,000,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 1,846,000,000 1,592,000,000 698,000,000
Depreciation & Amortization 1,269,000,000 1,196,000,000 1,136,000,000
Stock Based Compensation 266,000,000 233,000,000 220,000,000
Change in Working Capital -462,000,000 -770,000,000 -1,005,000,000
Operating Cash Flow 3,435,000,000 2,503,000,000 1,526,000,000
Investing Activities
Capital Expenditure -790,000,000 -800,000,000 -588,000,000
Investments -790,000,000 -711,000,000 -588,000,000
Investing Cash Flow -5,687,000,000 -2,574,000,000 -2,011,000,000
Financing Activities
Debt Repayment 1,827,000,000 -4,000,000 -165,000,000
Common Stock Issued/Repurchased 230,000,000 364,000,000 136,000,000
Dividends Paid 0 -28,000,000 -55,000,000
Financing Cash Flow 1,814,000,000 5,000,000 -548,000,000
Summary
Free Cash Flow 2,645,000,000 1,703,000,000 938,000,000
Net Change in Cash -449,000,000 -71,000,000 -1,036,000,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income 1,846,000,000 1,592,000,000 698,000,000
Depreciation & Amortization 1,269,000,000 1,196,000,000 1,136,000,000
Stock Based Compensation 266,000,000 233,000,000 220,000,000
Change in Working Capital -462,000,000 -770,000,000 -1,005,000,000
Operating Cash Flow 3,435,000,000 2,503,000,000 1,526,000,000
Investing Activities
Capital Expenditure -790,000,000 -800,000,000 -588,000,000
Investments -790,000,000 -711,000,000 -588,000,000
Investing Cash Flow -5,687,000,000 -2,574,000,000 -2,011,000,000
Financing Activities
Debt Repayment 1,827,000,000 -4,000,000 -165,000,000
Common Stock Issued/Repurchased 230,000,000 364,000,000 136,000,000
Dividends Paid 0 -28,000,000 -55,000,000
Financing Cash Flow 1,814,000,000 5,000,000 -548,000,000
Summary
Free Cash Flow 2,645,000,000 1,703,000,000 938,000,000
Net Change in Cash -449,000,000 -71,000,000 -1,036,000,000